The new science centre aims to accelerate AI research and personalized treatment in children’s health and it is based at the Icahn School of Medicine at Mount Sinai. The aim is to improve healthcare outcomes for children using AI. The Centre will develop AI-powered solutions to enhance diagnostics, personalize treatments, and optimise health care delivery for youth and adolescents.
Benjamin S. Glicksberg, an expert in digital health and clinical informatics, will lead the Center. He says: “The Center for AI in Children’s Health underscores Mount Sinai’s commitment to pioneering AI-driven technologies that will enable Mount Sinai to deliver world-class care to our children.”
Glicksberg adds: “As one of the first centers of its kind in New York City and nationwide, this unique and groundbreaking initiative positions Mount Sinai at the forefront of innovation in health care.”
It is hoped the research will generate more precise diagnostics and personalized treatments for our youngest patients, shaping the future of paediatric medicine.
The research centre also has objectives of developing robust paradigms for understanding the effects of genetics and the environment on the health of infants, children, and adolescents, and personalizing paediatric medicine through genetics and genomics.
Glicksberg notes that it is time for medicine aimed at treating children to catch up with AI’s technological wave: “While AI has advanced at a remarkable pace in many areas of medicine, paediatric medicine has unfortunately lagged due to stricter privacy considerations, more complicated regulatory pathways, and limited data infrastructure.”
AI continues to transform healthcare, however innovation remains significantly underrepresented in child health partly due to the specific standards involved. The new research will help to overcome some of these obstacles. This includes spearheading clinical trials for AI approaches to enhance diagnostics, predictive modelling, and real-time monitoring at Mount Sinai Kravis Children’s Hospital
In terms of how the new investment will help, Glicksberg indicates: “This new Center is dedicated to addressing these challenges by safely developing, testing, and embedding AI directly into child health care—enabling earlier diagnoses, preventive measures, computer-augmented imaging for complex conditions, expedited drug discovery, and highly personalized treatment plans. There’s no better place for this effort than Mount Sinai, or a more talented team of researchers to innovate alongside. I’m thrilled to lead this critical work and confident that we’re shaping a brighter future for child health care.”
Glicksberg hopes to advance personalized medicine aimed at children through multi-omics research, rare disease identification, and pharmacogenomics.
There are other ways through which AI can assist, including optimizing healthcare delivery to improve efficiency, patient outcomes, and resource allocation.
